OSR Holdings, Inc. (OSRHW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 25Sep 4Sep 10Sep 15Sep 18Sep 23Sep 28Oct 1

Key dataOct 1, 2026

Open$0.01

From 52W high−60.19%

Volume0.00

Market cap$133115.40

P/E (TTM)—

P/S (TTM)0.1x

Div yield—

Key dataOct 1, 2026

Open

$0.01

From 52W high

−60.19%

Volume

0.00

Market cap

$133115.40

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.6x

P/E (TTM)

—

RSI (14)

31.1

MomentumView details →

1D Return

−1.00%

YTD Return

−80.39%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.6x

EV/Sales

11.0x

P/S (TTM)

0.1x

P/B (TTM)

0.0x

ProfitabilityView details →

Gross Margin

−98.82%

Net Margin

−836.91%

EBITDA Margin

−423.86%

ROE (TTM)

−14.52%

ROA (TTM)

−9.08%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

+351.82%

EPS YoY

−16.42%

FCF YoY

—

Revenue CAGR 3Y

−17.69%

EPS CAGR 3Y

—

EBITDA YoY

−74.71%

MomentumView details →

1D Return

−1.00%

YTD Return

−80.39%

1Y Return

−74.42%

RSI (14)

31.1

vs 50D SMA

−69.27%

vs 200D SMA

−79.77%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

0.18x

Quick Ratio

0.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.03

EPS Surprise

88.50%

Beats (12Q)

2/12

Next Q EPS Est

—

Avg Surprise (4Q)

78.73%

Rev Surprise

−59.53%

Financials snapshotView financials →

Revenue (TTM)

1.81M

Net Income (TTM)

−15.14M

Op. CF (TTM)

−7.20M

Latest newsMore news →

OSR Holdings, Inc. changed its corporate name to OSR Health, Inc., effective June 11, 2026.120d ago

OSR Holdings, Inc. agreed to purchase all of Vaximm AG's right, title and interest in the VXM01 intellectual property family and certain related assigned contracts for $30 million.140d ago

Similar companies

Humacyte, Inc.HUMAW Altamira Therapeutics Ltd.CYTO Ainos, Inc.AIMDW CDT Equity Inc.CDT SAB Biotherapeutics, Inc.SABSW Vincerx Pharma, Inc.VINC Find similar companies →

Latest newsMore news →

OSR Holdings, Inc. changed its corporate name to OSR Health, Inc., effective June 11, 2026.120d ago OSR Holdings, Inc. agreed to purchase all of Vaximm AG's right, title and interest in the VXM01 intellectual property family and certain related assigned contracts for $30 million.140d ago Vaximm AG granted BCM Europe AG an exclusive, worldwide license to develop, manufacture and commercialize products based on VXM01.140d ago